Clinical Trials · NCT05683444

Octreotide Improves Human Lymphatic Fluid Transport a Translational Trial

CompletedEARLY_Phase 1Octreotide (Approved)
Phase
EARLY_Phase 1
Recruitment status
Completed
Sponsor
Rigshospitalet, Denmark
Enrollment
16
Start date
Jul 2020
Locations
1 site, Denmark
Primary endpoint
Lymph rate
View Octreotide compound reference